TY - JOUR
T1 - V1-like [Arg8]vasopressin binding sites occur in rat hepatocyte nuclei
AU - Phillips, Paddy A.
AU - Hutchins, Anne Marie
AU - Burrell, Louise M.
AU - Risvanis, John
AU - Johnston, Colin I.
PY - 1994/7/11
Y1 - 1994/7/11
N2 - Arginine vasopressin binding site characterization was performed on purified nuclei and plasma membranes from livers of Sprague-Dawley rats. [125I][d(CH2)5,Sarc7,Arg8]vasopressin, a selective V1 vasopressin receptor antagonist radioligand, bound to the nuclei in a protein concentration and time dependent manner. Scatchard analysis of nuclear binding sites revealed a single binding site with maximal binding site density (Bmax) of 115 ± 13 fmol/mg protein and affinity (KD) of 5.2 ± 0.7 nM. Plasma membrane binding demonstrated a Bmax of 529 ± 25 fmol/mg protein and KD of 1.9 ± 0.1 nM. The displacement profile for nuclear binding sites using vasopressin analogues was similar to that for plasma membrane binding sites and was typical of a V1 vasopressin receptor type. There was no evidence of V2-like vasopressin receptor binding using [3H]des-Gly-NH29[d(CH2)5,D-Ile2,Ile4,Arg8]vasopressin, a selective V2 vasopressin receptor radioligand, in the nuclear or membrane fractions. These results suggest the existence of nuclear V1-like vasopressin binding sites.
AB - Arginine vasopressin binding site characterization was performed on purified nuclei and plasma membranes from livers of Sprague-Dawley rats. [125I][d(CH2)5,Sarc7,Arg8]vasopressin, a selective V1 vasopressin receptor antagonist radioligand, bound to the nuclei in a protein concentration and time dependent manner. Scatchard analysis of nuclear binding sites revealed a single binding site with maximal binding site density (Bmax) of 115 ± 13 fmol/mg protein and affinity (KD) of 5.2 ± 0.7 nM. Plasma membrane binding demonstrated a Bmax of 529 ± 25 fmol/mg protein and KD of 1.9 ± 0.1 nM. The displacement profile for nuclear binding sites using vasopressin analogues was similar to that for plasma membrane binding sites and was typical of a V1 vasopressin receptor type. There was no evidence of V2-like vasopressin receptor binding using [3H]des-Gly-NH29[d(CH2)5,D-Ile2,Ile4,Arg8]vasopressin, a selective V2 vasopressin receptor radioligand, in the nuclear or membrane fractions. These results suggest the existence of nuclear V1-like vasopressin binding sites.
KW - Cell nucleus
KW - Peptide
KW - Vasopressin
KW - Vasopressin receptor
KW - Vasopressin receptor antagonist
UR - http://www.scopus.com/inward/record.url?scp=0028174778&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(94)90662-9
DO - 10.1016/0014-2999(94)90662-9
M3 - Article
C2 - 7982462
AN - SCOPUS:0028174778
SN - 0014-2999
VL - 259
SP - 325
EP - 329
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3
ER -